Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Regimen or Children or Adolescent With Mature B-cell NHL or B-AL in China

NCT02405676 is registered in ClinicalTrials.gov with Children's Cancer Group, China as lead sponsor.

NCT NCT02405676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02405676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Regimen or Children or Adolescent With Mature B-cell NHL or B-AL in China
Lead sponsor
Children's Cancer Group, China
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
January 1, 2015
Completion date
December 31, 2029
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mature b-cell non-hodgkin lymphoma